TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough breast cancer: drug aims to boost immune attack
Disease control TerminatedThis study tested the drug abemaciclib in 26 women with triple negative breast cancer that did not respond to standard chemotherapy. The goal was to see if the drug could increase immune cell activity in the tumor before surgery. The trial was stopped early, but results may help …
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Promising combo for Hard-to-Treat breast cancer hits roadblock
Disease control TerminatedThis study tested a combination of two drugs (nab-paclitaxel and alpelisib) given before surgery to people with a specific type of triple-negative breast cancer that didn't respond to standard chemotherapy. The goal was to see if the combo could shrink or eliminate tumors. Only 6…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:56 UTC